Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans

被引:53
作者
Brown, Jason J. [1 ,2 ,3 ]
Ollier, William [3 ]
Arscott, Guyan [4 ]
Ke, Xiayi [3 ]
Lamb, Janine [3 ]
Day, Philip [1 ,3 ]
Bayat, Ardeshir [1 ,2 ,3 ]
机构
[1] Univ Manchester, Manchester Interdisciplinary Bioctr, Plast & Reconstruct Surg Res, Manchester M1 7DN, Lancs, England
[2] Wythenshawe Hosp, Univ Hosp S Manchester NHS Fdn Trust, Dept Plast & Reconstruct Surg, Manchester, Lancs, England
[3] Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PL, Lancs, England
[4] Univ W Indies, Dept Plast Surg, Kingston 7, Jamaica
关键词
case-control association study; Keloid disease; skin scarring; SMAD; SNP; TGF-beta;
D O I
10.1111/j.1600-0625.2007.00654.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Keloid disease (KD) is a fibroproliferative dermal tumour of unknown aetiology. The increased familial clustering in KD, its increased prevalence in certain races and increased concordance in identical twins suggest a strong genetic predisposition to keloid formation. The highest incidence of keloids is found in the black population, where it has been estimated around 4-6% and up to 16% in random samples of black Africans. SMAD genes 3, 6 and 7 were investigated as candidate genes in Jamaican patients with keloid scars (n = 183) and a matched control population (n = 121) because of their previously reported involvement in fibrotic disorders and to determine if they were associated with keloid disease susceptibility. Thirty Five SNPs across these genes were genotyped using Time-of-Flight Mass Spectrometry (MALDI-TOF MS) and iPLEX assay. Linkage disequilibrium (LD) was established between several of the SNPs investigated. In the Jamaican population, the SMAD SNPs investigated for this study were not strongly associated with increased risk of developing KD. Identification of genetic markers in candidate genes such as the SMAD family may be of significant importance in diagnosis, prognosis and development of new therapies in the management of keloid scarring.
引用
收藏
页码:610 / 613
页数:4
相关论文
共 10 条
[1]   Spectrum of abnormal skin scars and their clinical management [J].
Bayat, A. ;
McGrouther, D. A. .
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (10) :527-532
[2]   Keloid disease: clinical relevance of single versus multiple site scars [J].
Bayat, A ;
Arscott, G ;
Ollier, WER ;
Mc Grouther, DA ;
Ferguson, MWJ .
BRITISH JOURNAL OF PLASTIC SURGERY, 2005, 58 (01) :28-37
[3]   Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population [J].
Bayat, A ;
Arscott, G ;
Ollier, WER ;
Ferguson, MWJ ;
Mc Grouther, DA .
BRITISH JOURNAL OF PLASTIC SURGERY, 2004, 57 (02) :122-133
[4]  
BLOOM D., 1956, NEW YORK STATE JOUR MED, V56, P511
[5]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[6]   Efficiency and power in genetic association studies [J].
de Bakker, PIW ;
Yelensky, R ;
Pe'er, I ;
Gabriel, SB ;
Daly, MJ ;
Altshuler, D .
NATURE GENETICS, 2005, 37 (11) :1217-1223
[7]   Smad3 as a mediator of the fibrotic response [J].
Flanders, KC .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2004, 85 (02) :47-64
[8]  
Marneros AG, 2001, ARCH DERMATOL, V137, P1429
[9]   REDUCED GROWTH-FACTOR REQUIREMENT OF KELOID-DERIVED FIBROBLASTS MAY ACCOUNT FOR TUMOR-GROWTH [J].
RUSSELL, SB ;
TRUPIN, KM ;
RODRIGUEZEATON, S ;
RUSSELL, JD ;
TRUPIN, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :587-591
[10]   Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring [J].
Yu, HY ;
Bock, O ;
Bayat, A ;
Ferguson, MWJ ;
Mrowietz, U .
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2006, 59 (03) :221-229